Literature DB >> 8368898

Current status of mycobacterial testing in clinical laboratories. Results of a questionnaire completed by participants in the College of American Pathologists Mycobacteriology E survey.

G L Woods1, F G Witebsky.   

Abstract

To learn what methods are used in clinical microbiology laboratories for detection, identification, and susceptibility testing of mycobacteria, questions addressing these issues were added to the College of American Pathologists' Mycobacteriology E proficiency testing survey, and participants in the survey were asked to complete the questionnaire. Other questions related to numbers of mycobacteriology tests performed and the frequency with which drug-resistant Mycobacterium tuberculosis is isolated. Just over half of the respondents stained smears for acid-fast bacilli with the fluorochrome stain. Only 26% of respondents processed respiratory specimens daily, potentially providing results within 24 hours of receiving the specimen. The most rapid methods currently available for detection of mycobacteria and for identification of M tuberculosis, respectively, were used by 30% and 35% of the respondents. Half of the respondents who performed susceptibility testing on isolates of M tuberculosis used rapid methods. Approximately 26% of the respondents indicated that they usually provided a final identification of M tuberculosis within 21 days of receiving a specimen, and 11% indicated that identification and susceptibility test results were reported within 28 days. Participants' responses indicated that the mean number of specimens received for mycobacterial culture per month was higher during the first 5 months of 1992 than it had been in 1991. Moreover, the number of drug-resistant M tuberculosis isolated per month from January through May 1992 was about double the number isolated per month in 1991.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8368898

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.

Authors:  Pawan K Angra; Thomas H Taylor; Michael F Iademarco; Beverly Metchock; J Rex Astles; John C Ridderhof
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

2.  U.S. hospital mycobacteriology laboratories: status and comparison with state public health department laboratories.

Authors:  J I Tokars; J R Rudnick; K Kroc; L Manangan; G Pugliese; R E Huebner; J Chan; W R Jarvis
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening.

Authors:  S J Heymann; T F Brewer; M Ettling
Journal:  Public Health Rep       Date:  1997 Nov-Dec       Impact factor: 2.792

Review 4.  Antimycobacterial susceptibility testing: present practices and future trends.

Authors:  C B Inderlied
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

5.  Comparison of solid and liquid culture media with polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples.

Authors:  J J Palacios; J Ferro; M Telenti; S G Roces; P Prendes; J M García; A I Nicolás; J Rodrígues; H Villar; J F de Quirós
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

Review 6.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 7.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

8.  Mycobacterial testing in clinical laboratories that participate in the College of American Pathologists' Mycobacteriology E survey: results of a 1993 questionnaire.

Authors:  G L Woods; F G Witebsky
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

9.  Evaluation of Amplicor PCR for direct detection of Mycobacterium tuberculosis from sputum specimens.

Authors:  K G Beavis; M B Lichty; D L Jungkind; O Giger
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Patient and health care system delays in the start of tuberculosis treatment in Norway.

Authors:  Mohamed Guled Farah; Jens Henning Rygh; Tore W Steen; Randi Selmer; Einar Heldal; Gunnar Bjune
Journal:  BMC Infect Dis       Date:  2006-02-24       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.